RxDoctor Payments Data

Ahmad Khaldi, MD

Neurological Surgery · Marietta, GANPI 1679736938

Payments from drug & device makers

What this record shows

20 manufacturers reported payments, led by Medtronic at 49.5% of the total. Reporting peaked in 2022 at $2,530 and has fallen 91.9% since, to $206 in 2025.

$5,401in general payments, 2019–2025

Across 66 payments — averaging $81.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Silk Road Medical, Inc.$873
  • Stryker$610
  • Microvention, Inc.$282
  • Scientia Vascular$155
  • Portola Pharmaceuticals, LLC$122
  • plus $684 from 14 others
$133,208in research payments, 2019–2025

Across 12 payments — averaging $11,101 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$96K
  • Medtronic$27K
  • Medical Device Business Services, Inc.$10K

What the payments were for

  • Travel & lodging$3,13658%
  • Food & beverage$2,26542%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,401 in reported general payments places this provider in the 55th percentile of 201 neurological surgery providers in Georgia.

See all neurological surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$116,057
Medicare patients
156
Services billed
461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate57$392

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →